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INTRODUCTION
Retinopathy of prematurity (ROP) has been 
identified as the major cause of childhood 
blindness [1, 2]. In prematurely born babies, 
the retina is only partially formed [3]. The state 
of retina development is directly correlated to 
the severity of prematurity [4, 5].
Retinopathy of prematurity is a multifacto-
rial disease that occurs most frequently in very 
small and very sick prematurely born babies 
[6, 7]. It has been believed for many years that 
oxygen therapy increases the risk of ROP in 
preterm infants [8]. However, ROP can occur 
even with careful control of oxygen therapy [9]. 
A number of risk factors have been implicated 
including low gestational age, low birth weight, 
increased number of blood transfusions [10], 
and the use of recombinant human erythropoi-
etin as treatment for anaemia [11]. Other iden-
tified risk factors include sepsis, intraventricu-
lar haemorrhage [12] and mechanical ventila-
tion [13].
OBJECTIVE
The aim of this study was to evaluate ROP inci-
dence and risk factors associated with varying 
degrees of illness.
METHODS
In the period from June 2006 to December 
2008, of 840 newborns admitted at the Centre 
for Neonatology of the Paediatric Clinic in 
Kragujevac, Serbia, 317 were screened for ROP. 
Screening was done in all newborns with birth 
weight (BW) < 2000 g, and/or gestational age 
(GA) < 36 gestational weeks (GW), as well as 
other newborns with severe diseases [4]. First 
ophthalmologic examination was conducted 
in the period between the third and the fifth 
week after birth. During the screening, find-
ings were formulated in accordance with the 
International Classification of Retinopathy of 
Prematurity (ICROP) [14]. Children with ROP 
were treated according to the recommendations 
from the ETROP study [15, 16].
Screened patients were divided into three 
groups: Group A infants without ROP, Group 
B infants with milder form of ROP, and Group 
C infants with severe form of ROP treated with 
laser.
We analyzed the following post-natal risk 
factors: gender, GA, Apgar score (AS), BW, dura-
tion of oxygen therapy, duration of mechani-
cal ventilation, number of transfusions, pres-
ence of sepsis, bronchopulmonary dysplasia 
(BPD), intraventricular haemorrhage (IVH) 
and/or periventricular leucomalacia (PVL) 
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and patent ductus arteriosus (PDA). We also analyzed the 
effect of medications: surfactant, erythropoietin, vitamin 
E, diuretics, dopamine and dexamethasone administered 
before birth [17].
Gestational age was determined from the date of the last 
period and examination by the neonatologist. The oxygen 
therapy was monitored using pulse oximetry and did not 
exceed the level of 95% [18-22]. We could not influence the 
oxygenation of the infant in the delivery room nor during 
transport (since patients are delivered to intensive care unit 
from ten regional hospitals). Surfactant was administered 
to infants that fulfilled the clinical and radiological criteria 
for respiratory distress syndrome (RDSy). Antenatal ster-
oid use was recommended for pregnancies between 24 to 
34 weeks with threatened premature delivery to decrease 
the risk of RDSy [23].
Patent ductus arteriosus was diagnosed using echocar-
diographic examination. IVH and PVL were presented 
jointly as central nervous system (CNS). IVH and PVL 
were diagnosed with a series of ultrasound examinations 
of central nervous system. BPD was diagnosed based on 
the clinical and radiological lung exam, and a continued 
need for oxygen therapy past 36 post-conception weeks 
[24]. Erythropoietin was administered in the dosage of 
200-250 IU/kg to infants in stable clinical condition, with 
GS less than 34 weeks after the second week of life. It was 
administered three times per week, with iron supplements, 
folic acid and vitamin E [28]. Vitamin E was administered 
after the second week of life to infants in stable clinical 
condition with BW less than 1500 g.
The following perinatal risk factors were also consid-
ered: premature rupture of foetal membranes, multiple 
pregnancies, chorioamnionitis, Caesarean section, EPH 
gestosis, and detachment of placenta.
Clinical data was subjected to statistical χ2 test, univari-
ate and multivariate regression analysis, and logistic regres-
sion. The χ2 test was used to examine the differences in the 
frequency of individual risk factors among the screened 
patient groups. Multivariate regression was used to estab-
lish the predictors of development of ROP. Logistical 
regression was used to establish the predictors of devel-
opment of ROP as well as the degrees of severity. The statis-
tical software SPSS 15.0 was used in the analysis.
RESULTS
Out of 317 screened patients, 125 (39.4%) were female and 
192 (60.6%) male. The average value of GA was 32.3±3.2 
GW (25 to 36). Average BW was 1819.2±437.6 g (700 to 
2910 g). Screened patients were divided into three groups: 
Group A infants without ROP (60.9%), Group B infants 
with a mild form of ROP (17.7%), and Group C infants 
with a severe form of ROP treated with laser (21.5%). The 
analysis of the risk factors of the observed patient groups 
is given in Table 1.
Next we analyzed group correlations for each of the 
risk factors using univariate regression. In particular we 
analyzed the correlation of Group A with Group B, Group 
A with Group C, and Group B with Group C. Statistical 
significance factors for this analysis is shown in Table 2.
Gender was found to have no statistical significance 
among the screened groups. High statistical significance 
of GA was found in all three groups. With respect to the 
group of infants without ROP, GA of infants with severe 
form of ROP was four weeks higher. AS had high statistical 
significance only in groups of healthy infants and infants 
with severe form of ROP, which confirms that perinatal 
asphyxia is a significant risk factor for the development 
of severe form of ROP. Birth weight exhibited statistical 
significance in all three groups. Mechanical ventilation 
had a high statistical significance for several forms of ROP, 
especially severe ROP. The infants with severe form of ROP 
were kept on mechanical ventilation on average five times 
longer than healthy infants. BPD was also found to signif-
icantly affect the development of severe forms of ROP.
Oxygen therapy was found to be a risk factor with a high 
statistical significance for the development of both mild 
Table 1. Retinopathy of prematurity risk factors analysis between three groups
Risk factors Group A Group B Group C
Number of patients 193 (60.88%) 56 (17.66%) 68 (21.46%)
Gender (boys/girls) 120/73 30/26 42/26
Gestational weeks 33.21±3.16 31.75±2.74 30.10±2.74
Birth weight (g) 1975.10±381.67 1738.66±408.43 1442.94±359.99
Apgar score 6.67±1.83 6.38±1.95 5.75±2.15
Duration of mechanical ventilation (days) 2.11±4.97 5.86±11.16 10.53±14.83
Duration of oxygen therapy (days) 13.94±10.60 22.82±22.24 33.97±22.26
Dysplasio bronchopulmonalis 5 (2.59%) 9 (16.10%) 16 (23.5%)
Intraventricular haemorrhage 11 (5.70%) 8 (14.3%) 8 (11.80%)
Periventricular leucomalacia 104 (53.90%) 37 (66.1%) 56 (82.4%)
Sepsis 39 (20.20%) 19 (33.9%) 28 (41.17%)
Patent ductus arteriosus 10 (5.20%) 4 (7.11%) 8 (11.80%)
Number of blood transfusions 1.24±1.49 2.46±2.19 3.95±3.08
Erythropoietin 9 (4.70%) 8 (14.30%) 16 (23.50%)
Surfactant 22 (11.40%) 17 (30.40%) 31 (45.60%)
Diuretics 28 (14.50%) 19 (33.90%) 38 (55.90%)
Dopamine 14 (7.30%) 13 (23.20%) 26 (38.20%)
Vitamin E 18 (9.30%) 15 (26.80%) 35 (51.50%)
Dexamethasone 28 (14.50%) 8 (14.30%) 19 (27.90%)435
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and severe forms of ROP, as well as transition from the mild 
to severe form. Infants with the severe form of ROP were 
exposed to oxygen therapy on average three times longer 
than healthy infants.
IVH and/or PVL were found to be highly significant 
risk factors for the development of mild and especially 
severe form of ROP, but they did not affect the transition 
from mild to severe form. In the group of healthy infants 
40.4% did not have CNS damage, while in groups with any 
form of ROP only 19.6% of infants did not have any CNS 
damage. IVH was most frequent in infants with some form 
of ROP (14.3%), while PVL was most frequent in infants 
with severe form of ROP (82.4%).
Sepsis was found to be a highly significant risk factor 
for the development of mild and severe forms of ROP and 
was especially uncorrelated to the transition from the mild 
to severe form of ROP. In infants with the severe form of 
ROP sepsis was found in 41.2% of cases.
The number of transfusions was also found to be a 
highly significant risk factor for the development of both 
types of ROP. The infants with the severe form of ROP 
received on average three times more transfusions than 
healthy infants.
Erythropoietin was found to be a highly significant 
factor of risk only for the development of severe forms of 
ROP. In this study, dexamethasone was not found to be a 
statistically significant risk factor, which indicates that the 
administration of dexamethasone potentially prevents the 
development of ROP. A hemodynamically significant PDA 
closed with Indomethacin was also not found to be a statis-
tically significant risk factor for the development of ROP.
Administration of surfactant was found to be a highly 
significant risk factor for the development of ROP, espe-
cially for severe forms of ROP. Surfactant was adminis-
tered to 45.6% of infants with severe form of ROP, 30.4% 
of infants with some form of ROP and 11.4% of infants 
which did not develop ROP.
Diuretics and Dopamine were found to be highly signif-
icant risk factors for the development of mild and espe-
cially severe forms of ROP. Diuretics were administered 
to 55.9% of infants with severe form of ROP and Dopa-
mine to 38.2%.
Vitamin E was found to be a highly significant risk factor 
for the development of all forms of ROP and significant 
factor in transition from mild to severe form of ROP. Vita-
min E received 51.5% of infants with severe form of ROP 
and only 9.3% of infants which did not develop ROP.
Out of six analyzed perinatal risk factors for develop-
ment of some form of ROP, Caesarean section was found 
to be statistically significant (p=0.01). None of these factors 
was found to have statistical significance for the develop-
ment of the severe form of ROP.
Multivariate logistical regression analysis was done for 
all risk factors which were found to be statistically signif-
icant by the univariate regression analysis. This analysis 
found independent risk factors for the development of ROP 
and for transition from mild to severe form of ROP. BW 
and CNS damage were found to be independent risk factors 
for the development of any form of ROP (Table 3). BW and 
prenatal factors were identified as independent risk factors 
for transition from mild to severe form of ROP (Table 4).
DISCUSSION
All factors that were found to be statistically significant 
using the univariate regression could have a direct impact 
on the development of ROP in addition to indicating the 
general condition of prematurely born and sick infants. 
ROP is a multifactorial disease, so univariate analysis is 
not a sufficient statistical method, which was also pointed 
out by other authors [4, 5, 25, 26]. While univariate anal-
ysis largely ignores the correlations of risk factors, multi-
variate logistical analysis reveals the mutual dependencies 
and is the method of choice for statistical analysis of risk 
factors in the development of ROP [26, 27]. Many authors, 
however, comment on the limitations of these multivari-
ate methods [4, 13].
In our study, BW was found as an independent risk 
factor for the development of any form of ROP and tran-
Table 3. Independent risk factors for any form of retinopathy of pre-
maturity
Risk factor Sig. Exp(B)
95% CI for Exp(B)
Lower Upper
Birth weight 0.001* 0.998 0.997 0.999
CNS damage 0.010* 2.019 1.185 3.438
* statistically significant; CNS – central nervous system
Table 4. Independent risk factors for transition from mild to severe form 
of retinopathy of prematurity
Risk factor Sig. Exp(B)
95% CI for Exp(B)
Lower Upper
Birth weight 0.052* 0.998 0.996 1.000
Pеrinatal risk 
factors 0.002* 1.433 1.144 1.794
* statistically significant
Table 2. Group correlations for each of risk factors using univariate re-
gression
Risk factors
p
A/B A/C B/C
Gender 0.248 0.952 0.359
Gestational age  0.000* 0.000* 0.002*
Birth weight  0.000* 0.000* 0.000*
Apgar score 0.037* 0.000* 0.119
Duration of mechanical ventilation  0.001* 0.000* 0.050*
Duration of oxygen therapy (days) 0.001* 0.000* 0.000*
Bronchopulmonary dysplasia  0.002* 0.000* 0.305
Central nervous system damage 0.001* 0.000* 0.218
Pеrinatal risk factors 0.013* 0.508 0.007*
Sepsis 0.033* 0.001* 0.410
Patent ductus arteriosus 0.083 0.017* 0.655
Number of blood transfusions  0.000* 0.000* 0.002*
Erythropoietin 0.012* 0.000* 0.197
Surfactant 0.001* 0.000* 0.084
Diuretics 0.001* 0.000* 0.015*
Dopamine 0.001* 0.000* 0.074
Vitamin E 0.001* 0.000* 0.005*
Dexamethasone 0.967 0.013* 0.068
* statistically significant436
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sition from milder to severe form, as shown by the authors 
from the Institute of Neonatology, Belgrade [28]. Many 
studies have shown that low BW and GA are most frequent 
statistically significant risk factors for the development 
and progression of ROP [3, 5, 6, 7]. Our analysis did not 
find the GA to be an independent risk factor for the devel-
opment of ROP. The possible cause is that our screening 
criterions included infants with higher GA and BW than 
those in the developed countries, where the severe form 
of ROP occurs in infants with BW less than 800 g and GA 
less than 26 weeks [27, 29]. The mean BW (1442.94±359.99 
g) and mean GA (30.10±2.74) in the severe ROP popula-
tion of our study group were comparable with those in 
infants in moderately and/or poorly developed countries.
[7, 30-35]. The second possible reason is the larger percent-
age of infants with intrauterine growth retardation, which 
was not analyzed separately in this study.
Brain damage in preterm infants (IVH and PVL) was 
found as an independent risk factor for the development 
of ROP, confirming the findings of other authors [36, 37]. 
Hungerford et al [38] have found that 78% of infants with 
a severe form of ROP had a periventricular haemorrhage. 
Similar relationship was discovered by Procianoy [39]. The 
majority of authors have pointed out a larger impact of IVH 
on the development of ROP (12), while our study found 
a larger percentage of infants with PVL. The frequency of 
PVL in all three groups was 62.14%, while the frequency 
of IVH was only 8.5%. Infants with a mild form of ROP 
more frequently had IVH, while infants with a severe form 
of ROP were found to have more frequent PVL. Other 
authors point out that the frequency of PVL is 4-26% in 
preterm infants in the neonatal intensive care unit (NICU) 
[40]. They point out that the incidence in autopsy stud-
ies is much larger and reaches 75%. Data on the frequency 
of PVL depend on the severity of the infant’s condition 
when accepted in NICU, number of ultrasound exami-
nations of CNS and the definition of PVL [41, 42, 43]. A 
large number of infants with PVL in our study is proba-
bly the consequence of early ultrasound CNS screening 
performed at our NICU, since in that way infants with tran-
sitional ischemic CNS developments were included in the 
study. The incidence of IVH ranges in literature from 20 
to 60% [43, 44, 45]. Other authors have shown that IVH is 
more frequent in infants with a very small BW and severe 
form of ROP [12].
Studies of ROP risk factor usually include well estab-
lished risk factors: oxygen therapy, small BW and GA, large 
number of transfusions, sepsis, CNS damage etc. In addi-
tion to these well established factors, many studies also 
include other factors without well understood pathogenetic 
mechanisms; surfactant, erythropoietin, vitamin E, dopa-
mine, diuretics, dexamethasone and others. Some studies 
also indicate the potential genetic predisposition for ROP. 
Lois Smith has determined that IGF-1 levels are deficient 
after premature birth, and that restoration of IGF-1 levels 
found in-utero may help prevent ROP [46]. In this study, we 
demonstrate that it is important to simultaneously consider 
all known risk factors, both peri- and postnatal. We would 
like to emphasize the impact of perinatal risk factors since 
this study shows their high statistical significance when 
analyzed together with postnatal factors. Univariate analysis 
was found the Caesarean section to be a statistically signif-
icant risk factor. Multivariate logistic regression showed 
that, in general, the existence of any pre-natal risk factor 
had impact on the development of severe form of ROP.
In our opinion, further studies of ROP risk factors 
should be directed toward establishing a common elec-
tronic database to include all known risk factors, both pre-
natal and post-natal. By utilizing an individual case-by-
case analysis and application of statistics and probabil-
ity theory on a larger data-set would enable the develop-
ment of properly calibrated weighted regression models 
that could capture complex interplays of many risk factors. 
This model would then enable the prediction of potential 
influence of post-natal risk factors based on the quantified 
impact of pre-natal risk factors.
CONCLUSION
Our study found a high statistical significance for multiple 
known individual risk factors for the development of ROP. 
The most significant independent risk factors for the devel-
opment of ROP were found to be BW and CNS damage. In 
addition to BW, prenatal risk factors were found as statis-
tically significant independent risk factors for the devel-
opment of severe form of ROP. According to our find-
ings, in the analysis of the ROP risk factors it is important 
to simultaneously consider prenatal, perinatal and post-
natal risk factors.
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КРАТАК САДРЖАЈ
Увод Ре  т и  н о  п а  т и  ј а  п р е  м а  т у  р и  т е  т а  ј е  м у л  т и  ф а к  т о р  с к а  б о  л е с т  
ко ја се нај че шће ја вља код ве о ма ма ле и бо ле сне пре вре ме-
но  ро ђе не  де це  и  нај зна чај ни ји  је  узрок  сле пи ла  код  де це.
Циљ ра  да Циљ ра  да је био да се ана  ли  зи  ра  ју уче  ста  лост и 
ф а к  т о  р и   р и  з и  к а   к о  ј и   у т и  ч у   н а   р а з  л и  ч и  т е   с т а  д и  ј у  м е   о в е   б о -
ле сти.
М е  т о  д е   р а  д а   Ст у д и  ј а   ј е   р а  ђ е  н а   у   Ц е н  т р у   з а   н е о  н а  т о  л о  г и  ј у  
Пе ди ја триј ске кли ни ке у Кра гу јев цу (Ср би ја) од ју на 2006. до 
де цем бра 2008. го ди не. Оф тал мо ло шким скри нин гом су об-
у  х в а  ћ е  н а   с в а   н о  в о  р о  ђ е  н а   д е  ц а   ч и  ј а   ј е   т е  л е  с н а   м а  с а   н а   р о -
ђ е  њу   б и  л а   д о   2 . 0 0 0   г р а  м а ,   о д  н о  с н о   д е  ц а   г е  с т а  ц и  о  н е   с т а  р о -
с т и   д о   3 6   н е  д е  љ а .   А н а  л и  з и  р а  н о   ј е   о с а м  н а  е с т   п о с т  н а  т а л  н и х  
и  шест  пе ри на тал них  фак то ра  ри зи ка  у  свим  по сма тра ним 
гру па ма, као и од нос из ме ђу гру па за сва ки фак тор по себ но.
Ре зул та ти Од 317 де це ко ја су под врг ну та оф тал мо ло шком 
скри  нин  гу, код 56 (17,7%) се раз  вио по  чет  ни об  лик ре  ти  но-
па  ти  је, док је код 68 де  це (21,5%) уста  но  вљен те  шки об  лик 
б о  л е  с т и .  Ун и  в а  р и  ј а н т  н о м  а н а  л и  з о м  о т  к р и  в е н  ј е  в е  л и  к и  б р о ј  
с т а  т и  с т и ч  к и   з н а ч а ј  н и х   ф а к  т о  р а   р и  з и  к а   з а   р а з  в о ј   р е  т и  н о  п а -
т и  ј е   п р е  м а  т у  р и  т е  т а ,   п о  с е б  н о   з а   р а з  в о ј   т е  ш к о г   о б  л и  к а   б о -
л е  с т и .   М у л  т и  в а  р и  ј а н т  н о м   л о  г и  с т и ч  к о м   а н а  л и  з о м   и з  д в о  ј е -
н и   с у   н е  з а  в и  с н и   ф а к  т о  р и   р и  з и  к а :   м а  л а   т е  л е  с н а   м а  с а   н а   р о -
ђе њу  (p=0,001)  и  оште ће ња  цен трал ног  нер вног  си сте ма 
(p=0,01).  Не за ви сни  фак то ри  ри зи ка  за  пре ла зак  бла жег  у 
т е  ж и  о б  л и к  р е  т и  н о  п а  т и  ј е  б и  л и  с у :  м а  л а  т е  л е  с н а  м а  с а  н а  р о -
ђе њу  (p=0,05)  и  пе ри на тал ни  фак то ри  (p=0,02).
За кљу чак М а л а  т е   л е   с н а  м а   с а  н а  р о   ђ е   њу  и  о ш т е   ћ е   њ а  ц е н -
трал ног  нер вног  си сте ма  би ли су фак  то  ри ри  зи  ка за раз-
в о ј  р е  т и  н о  п а  т и  ј е  к о д  п р е  в р е  м е  н о  р о  ђ е  н е  д е  ц е .  П е  р и  н а  т а л -
ни  фак то ри  ри зи ка  озна че ни  су  као  зна чај ни  за  по гор ша-
ње  обо ље ња.
Кључ не  ре чи:  р е  т и  н о  п а  т и  ј а   п р е  м а  т у  р и  т е  т а ;   ф а к  т о  р и   р и -
з и  к а ;   м у л  т и  в а  р и  ј а н т  н а   с т а  т и  с т и ч  к а   а н а  л и  з а
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